226 related articles for article (PubMed ID: 29746282)
1. Comparing the Effects of Atorvastatin With Sodium Valproate (Divalproex) on Frequency and Intensity of Frequent Migraine Headaches: A Double-blind Randomized Controlled Study.
Hesami O; Sistanizad M; Asadollahzade E; Johari MS; Beladi-Moghadam N; Mazhabdar-Ghashghai H
Clin Neuropharmacol; 2018; 41(3):94-97. PubMed ID: 29746282
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of magnesium, sodium valproate, and concurrent magnesium-sodium valproate therapy in the prevention of migraine headaches: a randomized controlled double-blind trial.
Khani S; Hejazi SA; Yaghoubi M; Sharifipour E
J Headache Pain; 2021 Apr; 22(1):21. PubMed ID: 33827421
[TBL] [Abstract][Full Text] [Related]
3. A randomized trial of propranolol versus sodium valproate for the prophylaxis of migraine in pediatric patients.
Bidabadi E; Mashouf M
Paediatr Drugs; 2010 Aug; 12(4):269-75. PubMed ID: 20593910
[TBL] [Abstract][Full Text] [Related]
4. Use of melatonin versus valproic acid in prophylaxis of migraine patients: A double-blind randomized clinical trial.
Ebrahimi-Monfared M; Sharafkhah M; Abdolrazaghnejad A; Mohammadbeigi A; Faraji F
Restor Neurol Neurosci; 2017; 35(4):385-393. PubMed ID: 28800342
[TBL] [Abstract][Full Text] [Related]
5. Cinnarizine and sodium valproate as the preventive agents of pediatric migraine: A randomized double-blind placebo-controlled trial.
Amanat M; Togha M; Agah E; Ramezani M; Tavasoli AR; Azizi Malamiri R; Fashandaky F; Heidari M; Salehi M; Eshaghi H; Ashrafi MR
Cephalalgia; 2020 Jun; 40(7):665-674. PubMed ID: 31707814
[TBL] [Abstract][Full Text] [Related]
6. The effects of cinnarizine versus sodium valproate in migraine prophylaxis.
Bostani A; Rajabi A; Moradian N; Razazian N; Rezaei M
Int J Neurosci; 2013 Jul; 123(7):487-93. PubMed ID: 23311688
[TBL] [Abstract][Full Text] [Related]
7. Levetiracetam in Compare to Sodium Valproate for Prophylaxis in Chronic Migraine Headache: A Randomized Double-Blind Clinical Trial.
Kashipazha D; Ghadikolaei HS; Siavashi M
Curr Clin Pharmacol; 2017; 12(1):55-59. PubMed ID: 28356053
[TBL] [Abstract][Full Text] [Related]
8. A comparative study of the effects of low-dose topiramate versus sodium valproate in migraine prophylaxis.
Afshari D; Rafizadeh S; Rezaei M
Int J Neurosci; 2012 Feb; 122(2):60-8. PubMed ID: 21950578
[TBL] [Abstract][Full Text] [Related]
9. Divalproex sodium in migraine prophylaxis: a dose-controlled study.
Klapper J
Cephalalgia; 1997 Apr; 17(2):103-8. PubMed ID: 9137847
[TBL] [Abstract][Full Text] [Related]
10. The preventive effect of the combination of atorvastatin and nortriptyline in migraine-type headache: a randomized, triple-blind, placebo-controlled trial.
Sherafat A; Sahebnasagh A; Rahmany R; Mohammadi F; Saghafi F
Neurol Res; 2022 Apr; 44(4):311-317. PubMed ID: 35037597
[TBL] [Abstract][Full Text] [Related]
11. Low-dose sodium valproate versus low-dose propranolol in prophylaxis of common migraine headache: A randomized, prospective, parallel, open-label study.
Dakhale GN; Sharma VS; Thakre MN; Kalikar M
Indian J Pharmacol; 2019; 51(4):255-262. PubMed ID: 31571712
[TBL] [Abstract][Full Text] [Related]
12. Sodium valproate in the prophylactic treatment of migraine: a double-blind study versus placebo.
Hering R; Kuritzky A
Cephalalgia; 1992 Apr; 12(2):81-4. PubMed ID: 1576648
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of magnesium oxide and sodium valproate in prevention of migraine headache: a randomized, controlled, double-blind, crossover study.
Karimi N; Razian A; Heidari M
Acta Neurol Belg; 2021 Feb; 121(1):167-173. PubMed ID: 30798472
[TBL] [Abstract][Full Text] [Related]
14. Divalproex extended-release in adolescent migraine prophylaxis: results of a randomized, double-blind, placebo-controlled study.
Apostol G; Cady RK; Laforet GA; Robieson WZ; Olson E; Abi-Saab WM; Saltarelli M
Headache; 2008 Jul; 48(7):1012-25. PubMed ID: 18705027
[TBL] [Abstract][Full Text] [Related]
15. Safety and tolerability of divalproex sodium extended-release in the prophylaxis of migraine headaches: results of an open-label extension trial in adolescents.
Apostol G; Pakalnis A; Laforet GA; Robieson WZ; Olson E; Abi-Saab WM; Saltarelli M
Headache; 2009 Jan; 49(1):36-44. PubMed ID: 19040678
[TBL] [Abstract][Full Text] [Related]
16. The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis--a double-blind, multicentre, randomized placebo-controlled dose-response study.
Pfaffenrath V; Diener HC; Fischer M; Friede M; Henneicke-von Zepelin HH;
Cephalalgia; 2002 Sep; 22(7):523-32. PubMed ID: 12230594
[TBL] [Abstract][Full Text] [Related]
17. A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis.
Freitag FG; Collins SD; Carlson HA; Goldstein J; Saper J; Silberstein S; Mathew N; Winner PK; Deaton R; Sommerville K;
Neurology; 2002 Jun; 58(11):1652-9. PubMed ID: 12058094
[TBL] [Abstract][Full Text] [Related]
18. Sodium valproate in migraine without aura and medication overuse headache: a randomized controlled trial.
Sarchielli P; Messina P; Cupini LM; Tedeschi G; Di Piero V; Livrea P; Pini LA; Bernardi G; Bono G; Sandrini G; Caproni S; Corbelli I; Pisani F; Beghi E; Calabresi P;
Eur Neuropsychopharmacol; 2014 Aug; 24(8):1289-97. PubMed ID: 24862255
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of carisbamate for the treatment of migraine in a randomized, double-blind trial.
Cady RK; Mathew N; Diener HC; Hu P; Haas M; Novak GP;
Headache; 2009 Feb; 49(2):216-26. PubMed ID: 19222595
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effect of topiramate and sodium valporate in migraine prevention: a randomized blinded crossover study.
Shaygannejad V; Janghorbani M; Ghorbani A; Ashtary F; Zakizade N; Nasr V
Headache; 2006 Apr; 46(4):642-8. PubMed ID: 16643559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
